CTWAS is a novel tool designed to spot genes that make us sick.
This novel tool applies advanced statistics to study complex data from the human genome and pinpoints the genes that cause illnesses.
The findings revealed that out of six children subjected to the gene therapy, five exhibited restored hearing and enhanced speech recognition.
Furthermore, the remaining incidents were ephemeral and had no lasting impact, showing that the detected adverse effects were just short and did not raise long-term issues.
“We are the first to initiate the clinical trial of OTOF gene therapy. It is thrilling that our team translated the work from basic research in animal model of DFNB9 to hearing restoration in children with DFNB9,” said Yilai Shu, lead study author from the Eye & ENT Hospital of Fudan University, in a press release.
Continue reading “Joint US-China gene therapy trials restore hearing in 5 kids, a first” »
This could possibly contribute towards saving lives.
Researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.
FDA approved the device by DermaSensor last week.
In a recent pioneering development, the US Food and Drug Administration (FDA) granted marketing authorization to the DermaSensor, an artificial intelligence-powered hand-held device designed for the early detection of skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma.
Predominantly tailored for use by primary care physicians, DermaSensor uses elastic scattering spectroscopy to look at cellular and subcellular characteristics of suspicious skin lesions.
Continue reading “US FDA approves world’s first AI-powered skin cancer detecting device” »
Soft robots, medical devices, and wearable devices are now common in our daily routines. Researchers at KAIST have created a fluid switch that employs ionic polymer artificial muscles. This switch functions with ultra-low power while generating a force 34 times its own weight. Fluid switches are designed to direct the flow of fluid, guiding it in specific directions to initiate different movements.
KAIST (President Kwang-Hyung Lee) announced on the 4th of January that a research team under Professor IlKwon Oh from the Department of Mechanical Engineering has developed a soft fluidic switch that operates at ultra-low voltage and can be used in narrow spaces.
The journey of aging brings with it an unavoidable reality for many: an increased accumulation of body fat.
Though much of society seems mostly focused on the aesthetics of being overweight, doctors look past any cosmetic concerns to focus on the health implications of fat byproducts in the body.
Continue reading “Critical Enzyme For Breaking Down Fat Byproducts Slows The Aging Process” »
Stanford researchers have developed a new phase-change memory that could help computers process large amounts of data faster and more efficiently.
We are tasking our computers with processing ever-increasing amounts of data to speed up drug discovery, improve weather and climate predictions, train artificial intelligence, and much more. To keep up with this demand, we need faster, more energy-efficient computer memory than ever before.
Innovations in Memory Technology.
Insects have been shown to have the ability to detect different chemical agents. Here, the authors present a nanomaterial-assisted neuromodulation strategy to augment the chemosensory abilities of insects via photothermal effect and on-demand neurotransmitter release from cargo-loaded nanovehicles to augment natural sensory function.
Posted for: stormykitteh Josh Layton Suspended in a deep freeze, the growing number of ‘patients’ at the world’s biggest cryo-preservation facilities are taking a dice roll at another life. Some ha…
Using CRISPR, an immune system bacteria use to protect themselves from viruses, scientists have harnessed the power to edit genetic information within cells. In fact, the first CRISPR-based therapeutic was recently approved by the FDA to treat sickle cell disease in December 2023. That therapy is based on a highly studied system known as the CRISPR-Cas9 genetic scissor.
However, a newer and unique platform with the potential to make large-sized DNA removals, called Type I CRISPR or CRISPR-Cas3, waits in the wings for potential therapeutic use.
A new study from Yan Zhang, Ph.D., Assistant Professor in the Department of Biological Chemistry at the University of Michigan Medical School, and her collaborators at Cornell University develops off-switches useful for improving the safety of the Type I-C/Cas3 gene editor. The study, “Exploiting Activation and Inactivation Mechanisms in Type I-C CRISPR-Cas3 for 3 Genome Editing Applications,” is published in the journal Molecular Cell.
